SomaLogic Competitors and Similar CompaniesClear all

SomaLogic's competitors and similar companies include Olink, Quanterix, PAI Life Sciences and Otsuka Novel Products.

	SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.	Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery.	Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.	PAI Life Sciences PAI Life Sciences is a biotechnology company that develops antigens for diagnostics and vaccines.	Otsuka Novel Products Otsuka Novel Products (ONPG) is a company dedicated to research and development of solutions for tuberculosis.
Founding Date	Founding Date 2000	Founding Date 2004	Founding Date 2007	Founding Date 2004	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development life sciences medical devices medical diagnostics	Tags Healthcare biotech pharma	Tags Healthcare biotech drug development life sciences medical diagnostics	Tags Healthcare biotech drug development life sciences medical diagnostics	Tags Healthcare biotech drug development life sciences medical diagnostics
Locations	Locations Boulder, US HQ	Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US	Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US	Locations Seattle, US HQ	Locations München, DE HQ
Employees	Employees 483	Employees 582	Employees 24840% increase	Employees N/A	Employees 323% increase
Valuation ($)	Valuation ($) 396.2 m	Valuation ($) N/A	Valuation ($) 506.2 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $97.7m (FY, 2022)	Revenue (est.) $169.6m (FY, 2023)	Revenue (est.) $138.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $51.9m (FY, 2023)	Cost of goods $73.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $119.9m (FY, 2023)	Gross profit $65m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($109.2m) (FY, 2022)	Net income ($31.6m) (FY, 2023)	Net income ($107.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 622.5m	Total funding raised N/A	Total funding raised $ 96.5m	Total funding raised N/A	Total funding raised N/A